140 related articles for article (PubMed ID: 29807039)
1. Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures.
Franco S; Buccione D; Pluvinet R; Mothe B; Ruiz L; Nevot M; Jordan-Paiz A; Ramos L; Aussó S; Morillas RM; Sumoy L; Martinez MA; Tural C
Antiviral Res; 2018 Jul; 155():106-114. PubMed ID: 29807039
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients.
Anadol E; Schierwagen R; Elfimova N; Tack K; Schwarze-Zander C; Eischeid H; Noetel A; Boesecke C; Jansen C; Dold L; Wasmuth JC; Strassburg CP; Spengler U; Rockstroh JK; Odenthal M; Trebicka J
Hepatology; 2015 Jan; 61(1):46-55. PubMed ID: 25125218
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/hepatitis C virus coinfections.
Franco S; Buccione D; Tural C; Martinez MA
AIDS; 2021 Jul; 35(9):1355-1363. PubMed ID: 33813557
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA profiles in serum samples from patients with stable cirrhosis and miRNA-21 as a predictor of transplant-free survival.
Amaral AED; Rode MP; Cisilotto J; Silva TED; Fischer J; Matiollo C; Morais Rateke EC; Narciso-Schiavon JL; Schiavon LL; Creczynski-Pasa TB
Pharmacol Res; 2018 Aug; 134():179-192. PubMed ID: 29935272
[TBL] [Abstract][Full Text] [Related]
6. There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV.
Souza AR; Tovo CV; Mattos AA; Chaves S
Braz J Med Biol Res; 2008 Mar; 41(3):223-8. PubMed ID: 18176724
[TBL] [Abstract][Full Text] [Related]
7. miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.
Bulfoni M; Pravisani R; Dalla E; Cesselli D; Hidaka M; Di Loreto C; Eguchi S; Baccarani U
J Med Virol; 2021 Aug; 93(8):4992-5000. PubMed ID: 33818800
[TBL] [Abstract][Full Text] [Related]
8. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].
Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression.
Shrivastava S; Petrone J; Steele R; Lauer GM; Di Bisceglie AM; Ray RB
Hepatology; 2013 Sep; 58(3):863-71. PubMed ID: 23390075
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
[TBL] [Abstract][Full Text] [Related]
11. Global microRNA expression profiling in the liver biopsies of hepatitis B virus-infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury.
Singh AK; Rooge SB; Varshney A; Vasudevan M; Bhardwaj A; Venugopal SK; Trehanpati N; Kumar M; Geffers R; Kumar V; Sarin SK
Hepatology; 2018 May; 67(5):1695-1709. PubMed ID: 29194684
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected.
Cairoli V; Valle-Millares D; Terrón-Orellano MC; Luque D; Ryan P; Dominguez L; Martín-Carbonero L; De Los Santos I; De Matteo E; Ameigeiras B; Briz V; Casciato P; Preciado MV; Valva P; Fernández-Rodríguez A
J Mol Med (Berl); 2023 Nov; 101(11):1409-1420. PubMed ID: 37704856
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNA expression levels in HIV-1-positive patients receiving antiretroviral therapy.
Marquez-Pedroza J; Cárdenas-Bedoya J; Morán-Moguel MC; Escoto-Delgadillo M; Torres-Mendoza BM; Pérez-Ríos AM; González-Enriquez GV; Vázquez-Valls E
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32319513
[TBL] [Abstract][Full Text] [Related]
14. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
[TBL] [Abstract][Full Text] [Related]
15. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
[TBL] [Abstract][Full Text] [Related]
16. Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors.
Alidjinou EK; Moukassa D; Ebatetou-Ataboho E; Mahoungou GH; Pambou JP; Sané F; Prevost B; Bocket L; Ibara JR; Hober D
J Infect Dev Ctries; 2014 Aug; 8(8):1068-71. PubMed ID: 25116677
[TBL] [Abstract][Full Text] [Related]
17. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
18. HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
Maponga TG; Andersson MI; van Rensburg CJ; Arends JE; Taljaard J; Preiser W; Glashoff RH
BMC Infect Dis; 2018 May; 18(1):214. PubMed ID: 29739341
[TBL] [Abstract][Full Text] [Related]
19. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
20. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
